Skip to content

Hair oil study in evaluating increase in hair growth, hair volume.

Clinical Evaluation of Efficacy and Safety of Ambhring Age Embrace Revitalizer Hair Oil in improving hair health including hair volume, hair softness, and hair strength in healthy adult volunteers

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052846
Enrollment
34
Registered
2023-05-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Ambhring Age Embrace Revitalizer Hair Oil: Apply about 4 pumps in a bowl of Ambhring Age Embrace Revitalizer Hair Oil and apply thoroughly on different areas of scalp. Use your fingerti

Sponsors

Transformative Learning Solutions Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male and female subjects in general good health. 2. Subjects in the age group of 18-55 years (both ages inclusive). 3. Subjects complaining of hair fall and damage. 4. Subjects willing to give a written informed consent and willing to abide by and comply with the study protocol. 5. Subjects falling under Grade 3 - Grade 6 of hair loss severity grade evaluated as per MSCR photo numerical 10-point scale (Linear scale for assessment purpose-In Use Scale).

Exclusion criteria

Exclusion criteria: 1.Subjects who have undergone hair growth treatment within 3 months before screening into the study. 2. Subjects having any active scalp disease which may interfere in the study – dermatologist’s judgement. 3. Subjects who have undergone chemotherapy for cancer in the 6 months prior to start of the study or have a plan to do treatments during study. 4. Subjects who have history of alcoholism, smoking, crash dieting and/ or psychiatric disorder including trichotillomania. Subjects who have had hair transplant, who have taken pharmaceutical product which cause hirsutism (ex. phenytoin) and finasteride for androgenic alopecia, under medical treatment for hair problems. 6. Subjects who consume vitamins and food supplements that may interfere with the study. 7. Subjects who wear wig or hair extensions 8. Subjects on oral medications, undergoing any chemical hair salon treatment straightening / perming / colour/ henna which will compromise the study. 9. Subjects with chronic illness which may influence the study. 10. Subjects who are pregnant or lactating or nursing as established with medical history 11. Menopausal female subjects as determined by medical history. 12. Subjects participating in other similar cosmetic or therapeutic trial within last three months. 13. Subjects with any history of underlying uncontrolled medical illness including diabetes mellitus, hypertension, HIV, hepatitis, severe anemia, serious disorder of heart and respiratory apparatus or any other serious medical illness.

Design outcomes

Primary

MeasureTime frame
1. Improvement in hair volume 2. Improvement in hair softness 3. Improvement in hair strength 4. Reduction in hair fall 5. Improvement in scalp condition 6. Improvement in hair thinningTimepoint: Day1, day 30 and day 60

Secondary

MeasureTime frame
the product safety profile by dermatologistsTimepoint: Day1, day 30 and day 60

Countries

India

Contacts

Public ContactSudhanthiran S

Transformative Learning Solutions Pvt Ltd

satyendra.kumar@transformative.in9891253516

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026